Identification of Important Modules and Biomarkers in Breast Cancer Based on WGCNA.
Onco Targets Ther
; 13: 6805-6817, 2020.
Article
en En
| MEDLINE
| ID: mdl-32764968
INTRODUCTION: Breast cancer (BRCA) has the highest incidence among female malignancies, and the prognosis for these patients remains poor. MATERIALS AND METHODS: In this study, core modules and central genes related to BRCA were identified through a weighted gene co-expression network analysis (WGCNA). Gene expression profiles and clinical data of GSE25066 were obtained from the Gene Expression Omnibus (GEO) database. The result was validated with RNA-seq data from The Cancer Genome Atlas (TCGA) and Oncomine database. The top 30 key module genes with the highest intramodule connectivity were selected as the core genes (R2 = 0.40). RESULTS: According to TCGA and Oncomine datasets, seven genes were selected as candidate hub genes. Following further experimental verification, four hub genes (FAM171A1, NDFIP1, SKP1, and REEP5) were retained. CONCLUSION: We identified four hub genes as candidate biomarkers for BRCA. These hub genes may provide a theoretical basis for targeted therapy against BRCA.
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
Idioma:
En
Revista:
Onco Targets Ther
Año:
2020
Tipo del documento:
Article